0001140361-20-011048.txt : 20200508 0001140361-20-011048.hdr.sgml : 20200508 20200508090030 ACCESSION NUMBER: 0001140361-20-011048 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200504 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Myovant Sciences Ltd. CENTRAL INDEX KEY: 0001679082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37929 FILM NUMBER: 20858921 BUSINESS ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB BUSINESS PHONE: 44 207-400-3351 MAIL ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB 8-K 1 form8k.htm 8-K
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 4, 2020
 
Myovant Sciences Ltd.
 
(Exact name of registrant as specified in its charter)
 
Bermuda
001-37929
98-1343578
(State or other jurisdiction of incorporation)
(Commission File No.)
(I.R.S. Employer Identification No.)

Suite 1, 3rd Floor
11-12 St. James’s Square
London SW1Y 4LB
United Kingdom
  
Not Applicable
(Address of principal executive office)
  
(Zip Code)
 
Registrant’s telephone number, including area code:  +44 207 400 3351
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:

 
Title of each class
  
Trading Symbol(s)
  
Name of each exchange on which registered
 
Common Shares, par value $0.000017727 per share
   MYOV
  
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company   ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On May 4, 2020, Kim Sablich, Chief Commercial Officer of Myovant Sciences, Inc., advised Myovant Sciences Ltd. that she was resigning from her position to take on a senior executive role at a multinational pharmaceutical company. Ms. Sablich’s last day of employment is expected to be May 22, 2020.
 
Item 8.01
Other Events.
 
Effective May 11, 2020, Adele Gulfo, Chief Business and Commercial Development Officer of Sumitovant Biopharma Inc. and board member of Myovant Sciences Ltd., will assume the role of interim Chief Commercial Officer, assuming commercial leadership responsibilities. Prior to joining Sumitovant, Ms. Gulfo served as Chief of Commercial Development at Roivant Sciences. She also served as Chief Strategy Officer, Executive Vice President, and Head of Global Commercial Development at Mylan, in addition to multiple executive leadership roles at Pfizer, including as President and General Manager of the U.S. primary care business unit. She has extensive experience in building commercial organizations and has led the launches of multiple new products, including LIPITOR®.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
Myovant Sciences Ltd.
   
Date: May 8, 2020
By:
/s/ Matthew Lang
   
Name:
Matthew Lang
   
Title:
General Counsel and Corporate Secretary


EX-101.SCH 2 myov-20200504.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 myov-20200504_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Amendment Flag City Area Code Entity Address, City or Town Entity Address, Country Country Region Document Period End Date Entity Incorporation, State or Country Code Local Phone Number Entity Address, Postal Zip Code Entity Address, State or Province Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Document Fiscal Year Focus Document Fiscal Period Focus Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity File Number Entity Emerging Growth Company EX-101.PRE 4 myov-20200504_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE JSON 5 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "form8k.htm" ] }, "labelLink": { "local": [ "myov-20200504_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "myov-20200504_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "myov-20200504.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "myov", "nsuri": "http://myovant.com/20200504", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form8k.htm", "contextRef": "c20200504to20200504", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://myovant.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form8k.htm", "contextRef": "c20200504to20200504", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://myovant.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 6 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 7 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information
May 04, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 04, 2020
Entity Registrant Name Myovant Sciences Ltd.
Entity Incorporation, State or Country Code D0
Entity File Number 001-37929
Entity Tax Identification Number 98-1343578
Entity Address, Address Line One Suite 1, 3rd Floor
Entity Address, Address Line Two 11-12 St. James’s Square
Entity Address, City or Town London
Entity Address, Country GB
Entity Address, Postal Zip Code SW1Y 4LB
Country Region 44
City Area Code 207
Local Phone Number 400 3351
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001679082
Title of 12(b) Security Common Shares, par value $0.000017727 per share
Trading Symbol MYOV
Security Exchange Name NYSE
XML 9 form8k_htm.xml IDEA: XBRL DOCUMENT 0001679082 2020-05-04 2020-05-04 false 0001679082 8-K 2020-05-04 Myovant Sciences Ltd. D0 001-37929 98-1343578 Suite 1, 3rd Floor 11-12 St. James’s Square London SW1Y 4LB GB 44 207 400 3351 false false false false Common Shares, par value $0.000017727 per share MYOV NYSE false XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 96 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://myovant.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports form8k.htm myov-20200504.xsd myov-20200504_lab.xml myov-20200504_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false ZIP 11 0001140361-20-011048-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-20-011048-xbrl.zip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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end